Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 208

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 208
---
.

<div align='center'>141

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.

PURSUANT TO 17 C.F.R. SECTION 200.83</div>

The Company will promptly notify the Private Warrant holders in writing of any adjustment to the exercise price or to the number of the outstanding Private Warrants, declaration of a dividend or other distribution, a special non-recurring cash dividend on or a redemption of the common shares, the authorization of a rights offering, the approval of the share holders required for any proposed reclassification of the common shares, a consolidation or merger by the Company, sale of all or substantially all of the assets of the Company, any compulsory share exchange, or the authorization of any voluntary or involuntary dissolution, liquidation, or winding up of the Company.

If at the time of exercise there is no effective registration statement for the sale of the common shares underlying the Private Warrants, or the offering circular or prospectus, as applicable, contained therein is not available for the issuance of the underlying shares to the holder, then, and only when held directly or beneficially owned by Armistice, the Private Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise" in accordance with the formula set forth in the full text of the Private Warrant.

No fractional shares or scrip representing fractional shares shall be issued upon the exercise of the Private Warrants. As to any fraction of a share which the holder would otherwise be entitled to purchase upon such exercise, we shall, at our election, either pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied by the exercise price of the Private Warrants or round the number of shares to be received by the holder up to the next whole number.

The Private Warrants contain a contractual provision stating that all questions concerning the construction, validity, enforcement and interpretation of the Private Warrants are governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law.

This summary of the Private Warrants is not complete, and is qualified in its entirety by, the full text of the Private Warrants and Warrant Agency Agreement in respect of the Private Warrants, copies of which have been filed with the SEC as exhibits to the registration statement of which this prospectus forms a part and are incorporated in this prospectus by reference.

<div align='center'>142

CONFIDENTIAL